Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation for the Evaluation of the Efficacy and Safety in Patients With Liver Cirrhosis

NCT01483248 is registered in ClinicalTrials.gov with S-Evans Biosciences Co., Ltd. as lead sponsor.

NCT NCT01483248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01483248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation for the Evaluation of the Efficacy and Safety in Patients With Liver Cirrhosis
Lead sponsor
S-Evans Biosciences Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
October 31, 2015
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system disease, fibrosis, liver cirrhosis, liver disease